- Benchmark ASINB0FRMNPR62
- MarketplaceUS
- Category ID3760901
- Analyzed Products
- Keywordhydrogen water tablets, molecular hydrogen tablets, effervescent hydrogen tablets
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing Cost¥11.90estimated
- Data Date2026-08-07
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场不适合进入。 新品牌只有12个、没有达到30+新品牌的“彻底过热”阈值，但已经出现明显拥挤和价格压力：近一年新上架产品盈利率只有39.13%，失败率60.87%，而且最近一段时间非盈利新品明显增多，说明竞争是在加剧，不是在变好。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing结论很明确：你有钱进入，但这个市场不适合现在进。 你的预算 500000 CNY 对单个 ASIN 的前期铺货、物流和投放是够的，但市场已经呈现明显的高竞争特征，利润好看的产品主要被少数老品牌和少量新品牌分走，普通跟卖式切入没有胜算。
从数据看，市场里可识别盈利产品占 40.00%，新上架产品盈利率 39.13%，表面不差；但真正能跑出来的案例，主要靠差异化功能 + 品牌包装 + 旧款延伸。例如 Crobirware 的 B0FX3TL43C、B0G91Q9WXF、B0GY8DMXT9 都是新品牌盈利款，单品利润率在 24.54%~26.67%，月销分别约 200~300 件，月收入约 322200~636900 美元；但同品牌也有 2 个新产品完全不赚钱，说明新品牌不是普遍可复制的成功。更关键的是，Dr. Mercola 作为老品牌，B0815T21XV 月销约 1000 件、月收入约 2151000 美元、利润率 31.79%，这是典型的大品牌碾压案例，不是小品牌可直接模仿的路径。市场同时存在明显“伪新手”信号：像 Dr. Mercola 这类老品牌单品 4233 reviews，而新品牌里也出现了 200+ reviews 的产品，已经接近高压营销打法，不是干净的小卖家环境。
对你来说，小商家可行性不高，且不值得硬闯；大品牌才有可能靠预算和品牌势能进去，但仍需重投放和长期品牌建设。如果一定要找参考对象，大品牌应盯住 Dr. Mercola 的 B0815T21XV；新品牌里可参考 Crobirware 的 B0FX3TL43C、B0G91Q9WXF、B0GY8DMXT9，以及 Sunshine & Rain 的 B0FRMNPR62（238 reviews、月收入约 1388100 美元、利润率高），但这些都不是低成本轻松复制的样板。短结论：别进这个市场；它更像是品牌战，不是低预算机会。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):39.13%Which new brands have these successful new listings?...Alternatives- 普通镁片/镁粉冲剂：很多用户购买氢水片其实是为了“恢复、放松、睡眠、抗疲劳”的感受，镁补充剂通常更便宜、渠道更广、服用方式更简单，替代成本更低。
- 电解质冲剂/口服补液粉：如果核心诉求是运动后补水、精神恢复和“饮用即得”的便捷性，电解质粉在便利店、电商都更容易买到，价格也通常低于氢水片。
- 维生素C泡腾片：同样是“泡一杯水就能喝”的形态，用户接受度高、使用门槛低，且常被用作日常抗氧化/提神替代方案，价格一般更亲民。
- 无咖啡因功能性饮料粉（如B族维生素饮料粉）：面向想要“提升精力、专注、代谢支持”的用户，比氢水片更直观、口味接受度更高，购买和使用更容易。
- 矿泉水+随身补剂方案：如果用户只是想获得“健康饮水”的心理替代，直接购买小包装矿泉水再搭配基础维矿补充剂，往往更省钱、也不需要等待溶解。
- 大包装天然矿物质/海盐电解质：对于追求“恢复感”和“补水仪式感”的用户，少量天然矿物质补充比氢水片更易理解，且常见于更多价位段，获取更容易。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不该进入：已经明显拥挤，且正在走向价格战。 现有样本里新品牌有12个、总共23个新上架产品；新品牌新上架盈利率只有39.13%，但失败率高达60.87%，而且2026年新增新品牌新品明显密集，说明竞争在加速，不是机会窗口而是拥挤窗口。
证据很直接：头部赚钱样本里，Dr. Mercola 的 B0815T21XV 以 21.51 美元售价、31.8%利润率、月销1000、月营收21,510美元，早期投入约44,314.65美元，属于典型大品牌重资源打法；Crobirware 作为新品牌，B0FX3TL43C / B0G91Q9WXF / B0GY8DMXT9 分别做到26.67% / 25.81% / 24.54%利润率，月销200~300、月营收322,200~636,900美元，但这些成功款的评论数只有14、140、174，说明它们更像“短期爆量样本”，不是稳定、可复制的低门槛路径。更重要的是，失败样本里 Klinovium 的 B0FXF568VY 和 B0H41PQ5JD 都是新品牌新品，虽然表面利润率仍有25.06%，却是 INACTIVE_SALES，其中 B0FXF568VY 只有2条评论、B0H41PQ5JD 甚至没有有效销量，这类产品说明在这个类目里“有利润率”并不等于“能卖出去”。
结论：大品牌也不是好进场，小商家更不该进场。 大品牌若硬要做，只能抄 Dr. Mercola 这种强品牌背书、成熟产品线和长期投放打法，但单个ASIN早期投入已到约44,315美元级别，且还不含研发、品牌和认证成本；小商家要找的“真成功案例”虽然有 Crobirware 这类新品牌，但它的成功已经很接近激进营销与强运营，不是普通小商家可轻松复制的模型。建议直接放弃，别进这个市场。
New products with Highest revenueCrobirware
Recent Monthly Revenue (USD):$6,369.00(300pcs/month)B0GY8DMXT9 (3.7/5 (14 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
Recent Monthly Revenue (USD):$5,061.00(300pcs/month)B0G91Q9WXF (3.8/5 (140 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
Recent Monthly Revenue (USD):$3,222.00(200pcs/month)B0FX3TL43C (3.7/5 (174 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableOld brand with the most profitable new productsDr. Mercola
Recent Monthly Revenue (USD):$21,510.00(1000pcs/month)B0815T21XV (4.2/5 (4233 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableMost investment in new productsLeast profitable new productsLeast investment in new productsKlinovium
Recent Monthly Revenue (USD):-(-)B0FXF568VY (5/5 (2 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):-(-)B0H41PQ5JDBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 柠檬黄包装，视觉更清新醒目
- |
- 复配NAC、肌酸，功能差异最大
- |
- 低价便携装，更容易吸引下单
B0FKN3RYLR (4/5 (148 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 深色琥珀瓶更显专业高级
- |
- 8个销量款差异明显，偏品牌感
- |
- 无味无添加，适合日常保健用户
B0FRMNPR62 (4.1/5 (238 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入，结论很明确：已经进入高竞争、接近价格战的状态，小品牌不应继续推进。 新品盈利率只有39.13%，但真正可复制的小品牌成功案例很少，更多是靠旧品牌背书或明显功能差异才跑出来；市场里没有出现30~100个新品牌的爆发式涌入，所以不是“彻底爆仓”，但已经足够拥挤，普通新品很难靠常规打法赚钱。
Profitability difficultyPotential high net profit marginAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0815T21XVDr. Mercola2019-11-07Yes$21.511000pcs$21510.031.79%$6838.03B0FRMNPR62Sunshine & Rain2025-09-10Yes$19.83700pcs$13881.031.72%$4403.06B0GY8DMXT9Crobirware2026-04-23Yes$21.23300pcs$6369.024.54%$1562.96B0G91Q9WXFCrobirware2025-12-19Yes$16.87300pcs$5061.025.81%$1306.25
B0GY4YG13BVitarevive2026-04-22Yes$19.99200pcs$3998.032.23%$1288.56B0FX3TL43CCrobirware2025-10-21Yes$16.11200pcs$3222.026.67%$859.31
B0GHXV2FPHSuiyilary2026-01-21Yes$22.36100pcs$2236.029.32%$655.6
B0GY8PRGM9Crobirware2026-04-23Yes$17.2650pcs$863.025.4%$219.21
B0GTTVH6MTCrobirware2026-03-25Yes$17.050pcs$850.023.1%$196.35B0FKN3RYLRWellcatcher2025-09-12Yes$10.09100pcs$1009.012.54%$126.53Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0FRMNPR62Sunshine & Rain2025-09-10Yes$19.83700pcs$13881.031.72%$4403.06B0GY8DMXT9Crobirware2026-04-23Yes$21.23300pcs$6369.024.54%$1562.96B0G91Q9WXFCrobirware2025-12-19Yes$16.87300pcs$5061.025.81%$1306.25B0GY4YG13BVitarevive2026-04-22Yes$19.99200pcs$3998.032.23%$1288.56B0FX3TL43CCrobirware2025-10-21Yes$16.11200pcs$3222.026.67%$859.31B0GHXV2FPHSuiyilary2026-01-21Yes$22.36100pcs$2236.029.32%$655.6B0GY8PRGM9Crobirware2026-04-23Yes$17.2650pcs$863.025.4%$219.21B0GTTVH6MTCrobirware2026-03-25Yes$17.050pcs$850.023.1%$196.35B0FKN3RYLRWellcatcher2025-09-12Yes$10.09100pcs$1009.012.54%$126.53#New Product Success Rates
Listing这个市场不适合进入，已经明显进入价格战/高竞争状态。新品牌新上架的盈利率只有39.13%，但失败率高达60.87%；更关键的是，近两个月新品牌连续出现大量非盈利上新，说明竞争在加剧而不是放缓。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
WellcatcherCrobirwareVitareviveSuiyilarySunshine & RainNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
KlinoviumPetlixaEssenWellOther#Success Rate by Entry Time
Listing这个市场现在不适合进入，已经进入高竞争/价格战风险区。 新品牌入场并没有形成健康扩张，反而是最近一年盈利新品占比只有39.13%（9/23），非盈利新品高达60.87%（14/23）；而且最近几个月失败明显抬头，2026年6月出现6个非盈利新品、7月又继续有非盈利案例，说明竞争在加剧，不是变容易。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 1 2 1 0 3 2026 0 0 0 0 4 1 0 11 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 1 0 1 0 0 2025/10 0 0 0 0 1 0 0 2 2025/11 0 0 0 0 0 0 0 1 2025/12 0 0 0 0 1 0 0 0 2026/1 0 0 0 0 1 0 0 1 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 1 0 0 0 2026/4 0 0 0 0 2 1 0 3 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 6 2026/7 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesDr. MercolaB0815T21XV (4.2/5 (4233 Reviews))Dr. Mercola H2 Molecular Hydrogen, 8 ppm, 30 Tablets (30 Servings)
This listing is deemed profitablePrice (USD)$21.51Released TypeOld Release (2019-11-07)Brand is an old entry in this marketSize and Weight8.9 x 4.4 x 4.4 cm, 127.00gProfitable Factors
Established brand with longevityBased on old ASINDesign & Appearance
瓶身与外盒采用深蓝配金色的高端保健品风格，整体辨识度强Key Buying Motive
主打8 ppm氢气生成浓度，并强调经过验证的生成工艺；相比竞品更偏品牌背书与稳定配方，而不是单纯堆高ppmTarget Customers
更适合信任Dr. Mercola品牌、关注脑健康/细胞能量/健康管理的中高端保健品用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$21,510.001000 sold in the past 30 days · as of 2026年8月Net Profit Margin
Sea Freight30.44% / 31.79%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight27.56% / 28.91%Peak / Non PeakSales & BSR Performance
WellcatcherB0FKN3RYLR (4/5 (148 Reviews))Hydrogen Tablets for Drinking Water: Molecular Hydrogen Tabs 12.4PPM with Magnesium NAC Creatine Supports Antioxidants Cellular Health Recovery Cognitive Function Vegan Organic Lemon Flavor
This listing is deemed profitablePrice (USD)$10.09Released TypeNew Release (2025-09-12)Brand is a new entry in this marketSize and Weight12.6 x 2.9 x 2.9 cm, 82.00gProfitable Factors
Distinct functions and featuresLow pricing strategyDesign & Appearance
柠檬黄配色，突出清新饮用感, 片剂+条状包装，强调便携冲泡；相比竞品更偏日常饮用场景Key Buying Motive
加入NAC、肌酸、亮氨酸等复配卖点，主打抗氧化、恢复和专注，不只是单一氢水片Target Customers
适合希望把氢水、运动恢复、日常提神合并购买的轻运动人群和办公室用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$1,009.00100 sold in the past 30 days · as of 2026年8月Net Profit Margin
Sea Freight9.98% / 12.54%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight6.01% / 8.57%Peak / Non PeakSales & BSR Performance
Loading samples... 20%